Skip to main content
Year archive

Pharming Group N.V. — 2017 filings

All 22 regulatory filings released by Pharming Group N.V. (PHARM) in 2017, sourced directly from the official regulator.

22 Filings
2017 Period
2017 filings (22)
Filing Released Lang
Pharming announces significant conversion of its Ordinary Convertible Bonds
Share Issue/Capital Change
2017-12-05 English
Pharming Submits Supplemental Biologics License Application to FDA for RUCONEST(r) for Prophylaxis of Hereditary Angioedema Attacks
Regulatory Filings
2017-11-27 English
Pharming Group reports financial results for the first nine months of 2017
Earnings Release 9M 2017
2017-10-26 English
Pharming announces positive data from paediatric clinical trial with RUCONEST®
Earnings Release Q4 2017
2017-10-02 English
Pharming Group N.V. and HAEi International Patient Organization announce partnership with Inceptua Medicines Access for “HAEi Global Access Program”
Regulatory Filings
2017-09-26 English
Pharming announces conclusion of FDA End of Phase
Regulatory Filings
2017-09-11 English
Pharming announces cashless warrant exercises and conversions of its Ordinary Bonds into shares
Share Issue/Capital Change
2017-08-10 English
Interim / Quarterly Report 2017
Interim / Quarterly Report H1 2017
2017-07-27 English
Pharming Reports on Financial Results for the First Half of 2017
Interim / Quarterly Report H1 2017
2017-07-27 English
Pharming announces publication of RUCONEST® prophylactic data in The Lancet
Regulatory Filings
2017-07-26 English
Pharming announces completion of its refinancing with a single US$100 million debt facility on improved commercial terms
Capital/Financing Update
2017-07-21 English
Pharming Reports On Annual General Meeting Of Shareholders
AGM Information
2017-05-25 English
Pharming Announces Withdrawal of Agenda Items Related to Amendment of the Articles of Association from AGM Agenda
AGM Information
2017-05-17 English
Interim Report on Financial Results for the First Quarter 2017
Interim / Quarterly Report Q1 2017
2017-05-17 English
A global awareness day for a rare life-threatening condition: World HAEday, 16th May 2017
Regulatory Filings
2017-05-16 English
Pharming announces refinancing of its existing debt by a single US$100 million debt facility on improved commercial terms
Capital/Financing Update
2017-05-16 English
Aankondiging AVA Pharming Group N.V. en publicatie AVA-stukken
AGM Information
2017-04-12 Dutch
Aankondiging AVA Pharming Group N.V. en publicatie AVA-stukken
AGM Information
2017-04-12 Dutch
Annual Report 2016
Annual Report FY 2016
2017-03-23 English
Pharming Group Reports on Preliminary Financial Results for 2016
Regulatory Filings
2017-03-09 English
Pharming announces issue of new stock as a result of conversion of Amortizing Bonds
Share Issue/Capital Change
2017-01-26 English
European Commission amends Marketing Authorisation for RUCONEST® to include self-administration
Regulatory Filings
2017-01-16 English